Chemistry:Remeglurant
From HandWiki
Short description: Chemical compound
 | |
| Clinical data | |
|---|---|
| Other names | MRZ-8456 |
| ATC code |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| Chemical and physical data | |
| Formula | C17H15BrN4O |
| Molar mass | 371.238 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Remeglurant (INN; developmental code name MRZ-8456) is a drug which acts as a selective antagonist of the mGlu5 receptor.[1][2][3] It is under development by Merz Pharmaceuticals for the treatment of drug-induced dyskinesia but no development has been reported since at least 2016.[3]
See also
References
- ↑ World Health Organization (2013). "International Nonproprietary Names for Pharmaceutical Substances (INN): Proposed INN: List 109". WHO Drug Information (World Health Organization) 27 (2). https://www.who.int/medicines/publications/druginformation/innlists/PL109.pdf.
- ↑ Danysz W, Dekundy A, Hechenberger M, Henrich M, Jatzke C, Nagel J, Parsons CG, Weil T, Fotins J, Gutcaits A, Kalvinsh I, Zemribo R, Kauss V, "Substituted pyrazolo[1,5-A]pyrimidines as metabotropic glutamate receptor modulators.", US patent 7985753, issued 4 August 2006, assigned to Merz Pharmaceuticals GmbH
- ↑ 3.0 3.1 "Remeglurant". Adis Insight. Springer Nature Switzerland AG. http://adisinsight.springer.com/drugs/800045269.
 |  |
